WEBRADR

WEB-RADR, funded by @IMI_JU, seeks to improve EU #pharmacovigilance through new technologies. All tweets represent the project as a whole, RT ≠ endorsement.

[Innovative Health Initiative @IHIEurope]

It's long proven difficult to reliably report drug side effects back to the company that made them once clinical trials are over. The @WEBRADR project have the solution
#IMICarryTheTorch
https://t.co/5Rn0BR9mmP

[Innovative Health Initiative @IHIEurope]

Our November newsletter is out, with news on our Stakeholder Forum + successes from our projects on #PatientsInvolved in #Japan, #depression & #ArtificialIntelligence, adaptive #ClinicalTrials, #MachineLearning, FAIR data, meds safety
➡️ https://t.co/GdgQgbNBPV
#IMICarryTheTorch

[WEBRADR @WEBRADR]

Read the @IMI_JU article on the #MedSafety App and WEB-RADR 1 and 2 projects, including work with #HALMED @WHO @UMCGlobalSafety @SnomedCT @MedDRAMSSO @ICH_news @abbvie
https://t.co/5tDzXIdMv1

[Innovative Health Initiative @IHIEurope]

Once clinical trials are over and drugs are approved for sale, there’s no easy or obvious way for side effects to get reported back to company that made them.

The @WEBRADR Med Safety App is fixing that.

#IMICarryTheTorch
https://t.co/5Rn0BR9mmP

[WEBRADR @WEBRADR]

Information and materials on the Med Safety App launch in Nigeria can be found on the WEB-RADR website https://t.co/dGOeviUJBF @NafdacAgency @WHO @UMCGlobalSafety @IMI_JU

[WEBRADR @WEBRADR]

The #MedSafety App has been launched in Pakistan! A great achievement by @DRA_Pakistan and collaboration @WHO @UMCGlobalSafety @IMI_JU @WEBRADR #MedSafetyApp #pharmacovigilance #DRAP

[Drug Regulatory Authority of Pakistan @DRA_Pakistan]

DRAP has launched a free mobile application for reporting adverse drug reactions. This app has been developed by MHRA, UK. It is handy, easy to use and available at google play store and ios.

[Drug Regulatory Authority of Pakistan @DRA_Pakistan]

#medsafety #medsafetyweek

[Drug Regulatory Authority of Pakistan @DRA_Pakistan]

##DRAP has developed "Med Safery App" for reporting ADRs. CEO DRAP explaining the effectiveness of this App. #MedSafetyWeek #medsafety

[Drug Regulatory Authority of Pakistan @DRA_Pakistan]

#MedSafetyWeek #DRAP

[Drug Regulatory Authority of Pakistan @DRA_Pakistan]

#MedSafetyWeek #DRAP

[Uppsala Monitoring Centre @UMCGlobalSafety]

After Nigeria's @NafdacAgency, it's time for @DRA_Pakistan to launch the Med Safety App. Congratulations!

If you want to know how the app works, check out this #UppsalaReports article by @MHRAgovuk and @WEBRADR colleagues: https://t.co/szpd97P2j3

#MedSafetyWeek

[WEBRADR @WEBRADR]

.@NafdacAgency have launched the #MedSafetyApp today! Download from the App Store or Google Play by searching 'Med Safety'

https://t.co/LWchgwfdbA

https://t.co/js5d5F0qke

[FDAGhana @fdaghana]

Reporting suspected side effects can lead to new warnings for patients and advice on how to use medicines safely.
Every report counts!
Check out the FDA's MEDSAFETY APP for more information about reporting suspected side effects.
#MedSafetyWeek #fdaghana

[Uppsala Monitoring Centre @UMCGlobalSafety]

Make sure to ask patients about any side effects they may be experiencing as a result of taking a medicine. Always report side effects to the medicines regulator in your country. By doing so, you help make medicines safer for everyone.

🔗 https://t.co/Zg4mo2DkrW

#MedSafetyWeek

[Uppsala Monitoring Centre @UMCGlobalSafety]

Congratulations to Nigeria's @NafdacAgency on the launch of the Med Safety App! If you're wondering how the app works, check out the thread below. 👇

Or read more in this #UppsalaReports article by @MHRAgovuk and @WEBRADR colleagues: https://t.co/szpd97P2j3

#MedSafetyWeek

[NAFDAC NIGERIA @NafdacAgency]

It's #MedSafetyWeek!
NAFDAC calls on patients and healthcare professionals to report all unwanted effects, especially those associated with new or experimental treatments using medicinal/pharmaceutical products, vaccines & biologics and medical devices

👉 https://t.co/g05WpUyIIo